Monsanto Company (MON) Receives “Equal Weight” Rating from Barclays PLC
Monsanto Company (NYSE:MON)‘s stock had its “equal weight” rating restated by equities researchers at Barclays PLC in a research note issued to investors on Thursday. They presently have a $124.00 price objective on the basic materials company’s stock, up from their previous price objective of $120.00. Barclays PLC’s target price points to a potential upside of 3.45% from the stock’s previous close.
Several other equities analysts also recently commented on MON. UBS AG downgraded Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Susquehanna Bancshares Inc reiterated a “neutral” rating and set a $128.00 price target (up previously from $125.00) on shares of Monsanto in a report on Tuesday, June 27th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a report on Tuesday, June 27th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $128.00 price target (up previously from $120.00) on shares of Monsanto in a report on Thursday, June 29th. Finally, BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Ten equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $125.64.
Monsanto (NYSE MON) traded down 0.24% during midday trading on Thursday, reaching $119.57. 680,813 shares of the company’s stock traded hands. Monsanto has a 52 week low of $97.35 and a 52 week high of $120.50. The stock has a market capitalization of $52.53 billion, a price-to-earnings ratio of 25.83 and a beta of 1.07. The company’s 50-day moving average price is $118.18 and its 200 day moving average price is $117.00. Monsanto also saw some unusual options trading on Wednesday. Investors bought 63,484 put options on the stock. This represents an increase of approximately 1,793% compared to the typical daily volume of 3,354 put options.
Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, beating the consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter last year, the company posted $0.07 earnings per share. The company’s revenue for the quarter was up 4.8% compared to the same quarter last year. On average, equities research analysts expect that Monsanto will post $5.65 earnings per share for the current year.
WARNING: “Monsanto Company (MON) Receives “Equal Weight” Rating from Barclays PLC” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/10/05/barclays-plc-increases-monsanto-company-mon-price-target-to-124-00.html.
In other news, VP Duraiswami Narain sold 2,860 shares of the firm’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.00, for a total value of $343,200.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the sale, the chief operating officer now owns 85,439 shares in the company, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. In the last 90 days, insiders sold 77,910 shares of company stock worth $9,242,439. 0.79% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently bought and sold shares of the business. Pinnacle Financial Partners Inc. acquired a new stake in Monsanto during the second quarter worth $114,000. Bruderman Asset Management LLC acquired a new stake in Monsanto during the second quarter worth $116,000. Tower Research Capital LLC TRC boosted its stake in Monsanto by 230.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after buying an additional 750 shares in the last quarter. JNBA Financial Advisors boosted its stake in Monsanto by 3.9% during the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock worth $135,000 after buying an additional 45 shares in the last quarter. Finally, Armbruster Capital Management Inc. boosted its stake in Monsanto by 12.2% during the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after buying an additional 125 shares in the last quarter. Hedge funds and other institutional investors own 74.81% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.